A clinical study of wintomylon in the treatment of shigellosis.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002675:Child, Preschool; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D006801:Humans; D066298:In Vitro Techniques; D007223:Infant; D007239:Infections / Q000188:drug therapy; D009268:Nalidixic Acid / Q000627:therapeutic use*; D012760:Shigella
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid